CV/COS Webinar: Clip 9

In the world of cancer care, different disease stages present unique challenges and experiences for patients. At Carevive, we recognize the importance of considering the stage of disease when analyzing the impact and quantification of tolerability, physical function, and symptoms. Early-stage disease patients may not be symptomatic, and treatment administration may have minimal interference as they work towards remission or cure. Real-world data collection allows us to gain valuable insights into the varying needs and experiences of patients at different stages, enabling us to tailor care strategies to meet their specific requirements and improve overall outcomes.

Recent Episodes

The U.S. healthcare system is under real strain—and it’s something both patients and physicians are feeling in everyday care. In Texas, those pressures are even more visible, where rapid population growth, rural access challenges, and regulatory complexity are making it harder for patients to get timely care and for doctors to focus on medicine…

Heart disease remains the leading cause of death in the U.S., with 683,491 deaths reported in 2024, according to the CDC. As cardiovascular care shifts toward access, prevention, and value-based outcomes, noninvasive therapies are gaining renewed attention for patients who continue to experience symptoms after traditional interventions. At the same time, rising healthcare costs…

Healthcare leadership is being redefined in real time. With the rise of AI, mounting financial pressures, and workforce burnout, executives today are operating in an environment of continuous disruption and uncertainty. In fact, industry leaders now rank workforce shortages and digital transformation among their top concerns—forcing a new kind of leadership that blends decisiveness…